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Objective: CeC chemokine receptor type 5 (CCR5) has been implicated in rheumatoid arthritis and
several inﬂammatory diseases, where its blockade resulted in reduced joint destruction. However, its role
in modulating cartilage and bone changes in post-traumatic osteoarthritis (OA) has not yet been
investigated. In this study, we investigated changes in articular cartilage, synovium and bone in a post-
traumatic OA model using CCR5-deﬁcient (CCR5/) mice.
Method: Destabilization of the medial meniscus (DMM) was performed on the right knee of 10-week old
CCR5/ and C57BL/6J wild-type (WT) mice to induce post-traumatic OA. The contralateral left knee
served as sham-operated control. Knee joints were analyzed at 4-, 8- and 12-weeks after surgery to
evaluate cartilage degeneration and synovitis by histology, and bone changes via micro-CT.
Results: Our ﬁndings showed that CCR5/ mice exhibited signiﬁcantly less cartilage degeneration than
WT mice at 8- and 12-weeks post-surgery. CCR5/ mice showed some altered bone parameters 18- and
22-weeks of age, but body size and weight were not affected. The effect of CCR5-ablation was insig-
niﬁcant at all time points post-surgery for synovitis and for bone parameters such as bone volume/total
volume, connectivity density index (CDI), structure model index (SMI), subchondral bone plate thickness,
and trabecular bone number, thickness and spacing.
Conclusion: These ﬁndings suggest that CCR5/ mice developed less cartilage degeneration, which may
indicate a potential protective role of CCR5-ablation in cartilage homeostasis. There were no differences
in bone or synovial response to surgery suggesting that CCR5 functions primarily in cartilage during the
development of post-traumatic OA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA), the most common degenerative joint dis-
ease of the U.S. population, affects many joint tissue processes
including articular cartilage, meniscus, and ligament degeneration,
subchondral bone remodeling, osteophyte formation, and inﬂam-
mation of the synovium (synovitis)1e5. Despite its widespread: L.J. Sandell, Department of
nter Washington University
uclid Ave. Campus Box 8233,
00; Fax: 1-314-454-5900.
(K. Takebe), raim@wudosis.
u (E.J. Schmidt), sandelll@
ternational. Published by Elsevier Loccurrence and consequences to society, the etiopathogenesis of
OA remains largely elusive. It is thought that OA is dependent on
multiple factors including degradative enzymes5, inﬂammatory
mediators6, cytokines3,7 and chemokines8,9. Chemokines are a
family of small structurally-related proteins8 that are involved in a
wide-array of inﬂammatory and infectious diseases including
OA8e10. Chemokines exert their biological functions through
binding to speciﬁc cell membrane receptors9,11.
We are interested in CeC chemokine receptor type 5 (CCR5) for
the following speciﬁc reasons: (1) CCR5 has been identiﬁed to serve
as a functional receptor for several inﬂammatory CeC-chemokines,
including macrophage inﬂammatory protein 1a (MIP-1a, also
called CeC motif ligand 3 or CCL3), MIP-1b (CCL4), and RANTES
(regulated on activation, normal T cell expressed and secreted, also
called CCL5)9,11,12, (2) in vitro studies in our laboratory have shown
that levels of many chemokines including CCL3, CeC motif ligand 3td. All rights reserved.
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drocytes in response to the pro-inﬂammatory cytokine interleukin
(IL)-1b and the adipokine resistin13e15, (3) CCR5 and its ligands
maintain the inﬂammatory process in rat adjuvant-induced
arthritis whereas blocking of CCR5 has resulted in reduced joint
destruction16e18, (4) CCR5 has been reported to be expressed in
normal and OA chondrocytes14,19,20 and its expression is elevated in
OA chondrocytes14,21 as well as after RANTES stimulation19, (5)
CCR5 has been found in synovial ﬂuid and synovial tissues of pa-
tients with rheumatoid arthritis22e24 as well as accumulation of
CCR5þ Tcells in the inﬂamed joint25,26 and ﬁnally, (6) CCR5 plays an
important role in the clearance of pro-inﬂammatory chemokines to
resolve inﬂammation27. Despite the important role of chemokines
and chemokine receptors in rheumatoid arthritis, direct evidence
for the role of CCR5 in post-traumatic OA is not available.
In this study, we evaluated the progression of post-traumatic
OA in CCR5-deﬁcient (CCR5/) and C57BL/6J wild-type (WT)
mice. We used the destabilization of the medial meniscus (DMM)
model to induce OA since this model provides practical ease and
reproducibility and resembles slow-progressing human OA28,29.
We hypothesized that removal of CCR5 in vivo would protect
mice from developing post-traumatic OA by protecting from
cartilage degeneration, synovial inﬂammation and OA-like bone
phenotype.
Method
Mice
All procedures were approved by the Washington University
Animal Studies Committee. CCR5/ (in a C57BL/6J background)
and C57BL/6J WT mice were procured from The Jackson Laboratory
(Bar Harbor, ME) as homozygous pairs. All mice in a genotype were
bred by brother-sister mating and raised at our mouse facility
operating at constant temperature of 21C and on a 12-h light/dark
cycle at high standards of sanitation. Offspring were housed with
their mothers until weaning at 3-weeks of age, and then separated
into sex-speciﬁc cages of 4e5 mice/cage with each cage individu-
ally ventilated. The genotypes of offspring were conﬁrmed by using
a genotyping kit (KAPA Biosystems, Boston, MA). All mice were fed
on irradiated rodent chow (Purina 5053, Purina Mills St. Louis, MO)
with food andwater provided ad libitum. Table I depicts the number
of mice and time points used in this study.
Induction of post-traumatic OA
OA was induced through DMM surgery in which the medial
meniscotibial ligament (MMTL) was transected in 10-week old
mice as described elsewhere28,29. Brieﬂy, mice were anesthetized
using an intra-peritoneal injection of rodent cocktail (100 mg/kg
ketamine, 20 mg/kg xylazine and 10 mg/kg acepromazine) before
their right knee MMTL was resected to displace the medial
meniscus. The contralateral left knee served as a sham, receivingTable I
Numbers of mice in each experimental group for each strain and time point
Genotype Time point N
WT 4 weeks 16
8 weeks 14
12 weeks 6
CCR5/ 4 weeks 14
8 weeks 16
12 weeks 6
Total 72the exact same surgery as DMM but without severing the MMTL.
Mice were sacriﬁced by CO2 asphyxiation at indicated time points.
Knees were harvested and subjected to histological and micro-CT
analyses.
Histological analysis of cartilage
The harvested knees were ﬁxed in 10% neutral-buffered-
formalin, decalciﬁed with 14% ethylenediaminetetraacetic acid for
6-days with constant shaking before embedding in parafﬁn. Coro-
nal sections (5-mm) were taken through the joint at eight levels
with each level separated by 80-mm intervals. From each level,
three sections were stained with toluidine blue for histological
assessment of cartilage and synovium. The changes in cartilage
were semi-quantitatively scored29,30 by two observers blinded to
mouse identity and surgical procedure. Histological cartilage scores
were assigned to four quadrants (medial tibial plateau, medial
femoral condyle, lateral tibial plateau, and lateral femoral condyle)
of each knee joint at all sectioned levels. For each individual,
summed OA scores (representing whole joint changes) and
maximum OA scores (representing the highest score within all
sectioned levels of a given knee) were calculated from all four
quadrants of each section29. The mean of the ﬁnal scores from each
time-point (4-, 8-, 12-weeks), genotype (CCR5/, WT) and proce-
dure (sham, DMM) were used for analysis.
Histological analysis of synovium
The synovial pathology (i.e., synovitis) was analyzed on all the
toluidine blue stained sections fromwhich summed and maximum
OA scores were obtained. Degree of synovitis was scored using a
published synovitis scoring system31 that measured the enlarge-
ment of the synovial lining cell layer on a scale of 0e3 (0 ¼ 1e2
cells, 1 ¼ 2e4 cells, 2 ¼ 4e9 cells and 3 ¼ 10 or more cells) and
cellular density in the synovial stroma on a scale of 0e3
(0 ¼ normal cellularity, 1 ¼ slightly increased cellularity,
2 ¼ moderately increased cellularity and 3 ¼ greatly increased
cellularity). Synovitis scores obtained from all four quadrants
(medial tibia, medial femur, lateral tibia, and lateral femur)
[Fig. 1(AeB)] for both of the above parameters were averaged
separately and then the sum of averages from both parameters was
used for analysis (on a scale of 0e6).
Micro-CT analysis of bone
Prior to decalciﬁcation, knee joints were scanned using a vivaCT-
40 micro-CT scanner (Scanco-Medical, Bassersdorf, Switzerland)
for analysis of 3-dimensional structure of bone for several param-
eters as described previously29,32 with the following setting: voxel
size ¼ 21 mm, energy ¼ 45 kV, intensity ¼ 177 mA and integration
time ¼ 300 ms. In order to analyze bone changes, the epiphysis of
the proximal tibia was chosen as the region of interest. The region
of interest was identiﬁed between the cartilage and the growth
plate [Fig. 2(A)]. The outline of the epiphysis was carefully selected
without inclusion of outgrowing osteophyte(s). The following
morphometric parameters33 of the tibial cancellous bone were
calculated for trabecular compartments: trabecular bone volume
fraction (BV/TV), i.e., the ratio of trabecular bone volume to endo-
cortical total volume, trabecular thickness (Tb.Th.), trabecular
separation (Tb.Sp.), trabecular number (Tb.N.) and structure model
index (SMI). SMI, an indicator of structure of trabecular bone, is
designed so that a 0 ¼ parallel plate-like trabecular bone,
3 ¼ cylindrical rod-like structure and 4 ¼ perfect spheres33. The
bone parameters documented here are not only standard
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changes in OA29,32,34.
The subchondral bone thickness was outlined separately from
trabecular bone at the tibia using the contouring methods on the
cortical regions and measured the same algorithm as used for
determining Tb. Th [Fig. 2(B)].
Statistical analysis
For each phenotype, we performed analysis of variance using
the factors genotype (CCR5/, WT) and procedure (sham, DMM)
and the genotype-by-procedure interaction.
The interaction term controls for between genotype tissue dif-
ferences present prior to surgery. F is the fundamental test statistic
used in analysis of variance, and is calculated as the ratio of the
mean squares of the factors (between group variation) and residual
error (within group variation). We set the probability of signiﬁ-
cance of a factor at 0.05. When signiﬁcant, the genotype-by-
procedure interaction indicates differences between CCR5/ and
WT in surgical response and thus the effect of CCR5-ablation on the
OA phenotype. In these cases, we used Tukey's post-hoc adjust-
ments of standard errors in pair-wise comparisons of sham- and
DMM-operated knees of WT and CCR5/ mice, and report 95%
conﬁdence intervals for signiﬁcant contrasts.Fig. 1. Analysis of synovitis in CCR5¡/¡ and WT mice. Enlargement of synovial lining
cell layer and density of the cells were obtained from all four quadrants (medial tibia,
medial femur, lateral tibia, and lateral femur). The evaluation areas were white four-
sided ﬁgures which were between the bone (femur or tibia) and ligament. (A)
medial side of the knee (B) lateral side of the knee. Magniﬁcation 40 (Scale
bar ¼ 500 mm). F ¼ femur; T ¼ tibia; L ¼ ligament; LM ¼ lateral meniscus;
MM ¼ medical meniscus.Results
Gross appearance and body weight
CCR5-ablation did not result in any overt phenotype or devel-
opmental abnormalities since both CCR5/ and WT mice grossly
appeared alike as has also been reported by The Jackson Laboratory
datasheet (http://jaxmice.jax.org/strain/005427.html). The average
bodyweight of CCR5/ (22.53 ± 0.51 g) and WT (22.57 ± 0.39 g)
mice at 10-weeks of age was equal.
Cartilage analysis in CCR5/ and WT mice
Representative sections from CCR5/ and WT sham joints at 8-
weeks post-surgery are shown in Figs. 3(A) and 1(B). There was
decreased cartilage degeneration in CCR5/ compared toWTmice
at 8- [Fig. 3(C and D)] and 12-weeks after induction of DMM.Fig. 2. Micro-CT analysis of bone changes. (A) The subchondral bone plate thickness
was outlined (white shaded areas) separately from trabecular bone of the tibia using
the contouring methods on the cortical regions and measured the same algorithm as
used for determining Tb. Th. (B) The epiphysis of proximal tibia was selected as region
of interest (outlined by white line). We were only interested in bone changes occurring
in the epiphysis, i.e., area between the articular cartilage and the growth plate.
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Fig. 3. Histological evaluation for cartilage degeneration in CCR5¡/¡ and WT mice. The sham-operated side of both CCR5/ (A) and WT (B) mice after DMM showed normal
cartilage with no osteophyte formation at 8-weeks after DMM. Following DMM at 8-weeks, decreased articular cartilage degeneration (complete arrow) in CCR5/ (C) compared to
WT mice (D) was observed. Osteophyte formation was also observed on the medial side in both CCR5/ and WTmice (arrowhead). The sum OA score from all four quadrants of ﬁve
sections from each level with eight levels from each knee was based on cartilage damage and shows that CCR5/ mice develop less OA compared to WT mice after surgery only at
8-weeks (N ¼ 14 for WT, N ¼ 16 for CCR5/) (G) and 12-weeks (N ¼ 6 each genotype) (I) but not at 4-weeks post-surgery (N ¼ 16 for WT, N ¼ 14 for CCR5/) (E). Pair-wise
comparison showed that the summed OA score was found to be signiﬁcantly lower in DMM knees of CCR5/ compared to WT mice at 8- (P < 0.01; 95% CI ¼ 5.52e20.02 in
CCR5/) and 12-weeks (P < 0.01; 95% CI ¼ 1.10e1.86 in CCR5/) post-surgery. A maximum score (F, H, J) representing highest score from all sectioned levels for a given knee
indicates that DMM knees have signiﬁcant more OA score in both CCR5/ and WT mice compared to sham knees. It was also shown that there was no signiﬁcant difference
between CCR5/ mice and WT mice for maximum OA score at any time point post-surgery. MFC ¼medial femoral condyle; LFC ¼ lateral femoral condyle; MM ¼medial meniscus;
LM ¼ lateral meniscus; T ¼ Tibia. Images in the left panel have magniﬁcation of 40 and scale bar ¼ 300 mmwhile images in the right panel have magniﬁcation of 100 and scale
bar ¼ 100 mm. Higher magniﬁcation images of the selected box showed right to the lower magniﬁcation images. Asterisks (*) indicate P < 0.05. Graphs represent mean ± 95% CI.
K. Takebe et al. / Osteoarthritis and Cartilage 23 (2015) 454e461 457WhereasWTmice showeda loss of proteoglycan staining alongwith
cartilage ﬁbrillation in the superﬁcial zone [Fig.1(D)], CCR5/mice
demonstrated a focal loss of proteoglycan staining without severe
loss in cartilage post-surgery [Fig. 3(C)]. Osteophyte formation was
observed on the medial side in both CCR5/ and WT mice.Statistical analysis of summed OA scores (across all four quad-
rants) showed that there is no signiﬁcant genotype-by-procedure
interaction effect at 4-weeks after surgery. However, this effect
reached a borderline signiﬁcance (P ¼ 0.058) at the 8-week and
formal signiﬁcance (P ¼ 0.039) at the 12-week time point (Table II).
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found to be signiﬁcantly lower in DMMknees of CCR5/ compared
to WT mice at 8- (P < 0.01; 95% CI ¼ 5.52e20.02 for CCR5/) and
12-weeks (P < 0.01; 95% CI ¼ 1.10e1.86 for CCR5/) post-surgery
[Fig. 1(GeI)]. The maximum OA score that represents the highest
score in any of the knee cartilage compartments was not signiﬁ-
cantly different between the two genotypes [Fig. 1(F, H and J)].
Synovium analysis in CCR5/ and WT mice
No signiﬁcant differences were detected for synovial score
(Table II) at any time point post-surgery. Synovitis scores for WT
and CCR5/ DMM-operated knees were not signiﬁcantly inﬂu-
enced by variation in genotype [Fig. 4(AeG)]. Post-surgical
inﬂammation of synovium (i.e., synovitis) appeared to decrease in
shams for 8- and 12-week time points compared to 4-week time
point, whereas that of DMM limb persisted. This was to be expected
given that post-surgical inﬂammation was higher at earlier time
points. We failed to ﬁnd any signiﬁcant difference in degree of sy-
novitis between the two genotypes/procedure combinations at any
of the time points studied.
Analysis of bone phenotype
We examined bone of the distal tibia by comparing values for
these parameters: BV/TV, connectivity density index (CDI), SMI,
subchondral bone plate thickness, Tb.N., Tb.Th., and Tb.Sp. We used
analysis of variance to ﬁnd signiﬁcant genotype-by-procedure in-
teractions that would indicate CCR5-ablation causes a different
surgical response compared to wild type. By this analysis, we found
very few signiﬁcant differences by genotype (BV/TV, SMI, sub-
chondral bone thickness, and Tb.Th.) and by procedure (sub-
chondral bone thickness, CDI, Tb.Th., BV/TV, and SMI). We did
observe a signiﬁcant interaction at 4 weeks for trabecular thickness
(Table II), but it disappeared by 8- and 12-weeks. These results
suggest no differences in bone quality between CCR5/ andWT in
response to traumatic injury (DMM-surgery).
Discussion
Chemokines exert their effects through binding to speciﬁc cell
membrane receptors9,11. Functionally, they can be divided intoTable II
F ratios and associated P values for various parameters studies for CCR5/ and WT mice
Time point Effects Summed
OA score
Max OA
score
Synovium BV/TV
4 weeks Genotype F ¼ 0.016 F ¼ 0.618 F ¼ 0.716 F ¼ 0.036
P ¼ 0.900 P ¼ 0.439 P ¼ 0.405 P ¼ 0.848
Procedure F ¼ 17.124 F ¼ 8.584 F ¼ 0.373 F ¼ 0.022
P < 0.001 P ¼ 0.006 P ¼ 0.546 P ¼ 0.880
Genotype*procedure F ¼ 1.689 F ¼ 1.939 F ¼ 0.247 F ¼ 1.057
P ¼ 0.205 P ¼ 0.175 P ¼ 0.623 P ¼ 0.308
8 weeks Genotype F ¼ 7.267 F ¼ 1.531 F ¼ 1.680 F ¼ 5.022
P ¼ 0.011 P ¼ 0.224 P ¼ 0.203 P ¼ 0.029
Procedure F ¼ 63.105 F ¼ 75.004 F ¼ 14.046 F ¼ 0.282
P < 0.001 P < 0.001 P ¼ 0.001 P ¼ 0.597
Genotype*procedure F ¼ 3.820 F ¼ 1.808 F ¼ 0.678 F ¼ 2.151
P ¼ 0.058 P ¼ 0.187 P ¼ 0.415 P ¼ 0.148
12 weeks Genotype F ¼ 1.662 F ¼ 0.030 F ¼ 0.584 F ¼ 5.959
P ¼ 0.222 P ¼ 0.865 P ¼ 0.458 P ¼ 0.040
Procedure F ¼ 5.306 F ¼ 5.435 F ¼ 14.428 F ¼ 0.092
P ¼ 0.040 P ¼ 0.038 P ¼ 0.002 P ¼ 0.768
Genotype*procedure F ¼ 5.304 F ¼ 1.453 F ¼ 3.180 F ¼ 0.403
P ¼ 0.040 P ¼ 0.251 P ¼ 0.097 P ¼ 0.543
BV/TV ¼ trabecular bone volume fraction, the ratio of trabecular bone volume over endoc
Tb.N. ¼ trabecular number, Tb.Th. ¼ trabecular thickness, Tb.Sp. ¼ trabecular separationinﬂammatory, homeostatic, and angiogenic/angiostatic chemo-
kines8. Several chemokines are expressed at elevated levels in OA
chondrocytes, proposed to be due to an abnormal mechanical
stress8,35. The role of chemokines in post-traumatic OA has not
been investigated. Molecular studies demonstrate that cartilage
chondrocytes produce substantial quantities and varieties of CCR
ligands and chemokines in response to cytokines14,15,19,20, and the
genes for CCL3 and CCL4 are regulated by the transcription factors
NF-kB and C/EBPb known to be involved in OA13. Therefore, we
took the approach to study post-traumatic OA in mice deﬁcient in
CCR5.
This study shows that mice lacking CCR5 are less susceptible to
post-traumatic OA as evidenced by a signiﬁcant reduction in
cartilage degeneration in CCR5/ mice after DMM surgery
compared toWTcontrol mice. Therewere no signiﬁcant differences
in the degree of synovitis and bone metabolic parameters between
CCR5/ and WT mice in response to DMM surgery. In addition,
there was no difference in osteophyte formation between CCR5/
and WT mice, which reﬂects a normal anabolic process in both
genotypes.
We observed that CCR5/ mice exhibit signiﬁcantly less carti-
lage degeneration than WT mice, strongly suggesting involvement
of CCR5 in cartilage degeneration. While differences in articular
cartilage degeneration were not seen between CCR5/ and WT
mice at the early 4-week time point, theywere observed at the later
8- and 12-week time-points, a time line that has been shown
previously for other mouse strains29,32. While degeneration of
articular cartilage is considered a hallmark of end-stage OA36,37,
observing less degeneration in CCR5/mice suggests some degree
of protection from developing post-traumatic OA.
We found a signiﬁcant genotype-by-procedure interaction ef-
fect for the summed OA score but not for maximum OA score. The
absence of signiﬁcance for maximum OA score is attributable to the
nature of scoring system: any out of range score in summed OA
scoring system is covered by the calculation of means across all the
sectioned levels. In contrast, for maximum OA scoring, one has to
take into consideration the maximum score in any one of the sec-
tions without calculating means across all sections. Thus, the
CCR5/ mice showed less widespread areas of cartilage destruc-
tion compared to WT control mice.
Under normal physiological conditions the synovial lining is
made up of a thin layer of cells35, while in OA the synovium showsby time points
CDI SMI Tb.N. Tb.Th. Tb.Sp. Subchondral
bone thickness
F ¼ 0.141 F ¼ 0.249 F ¼ 0.385 F ¼ 0.840 F ¼ 0.026 F ¼ 1.870
P ¼ 0.708 P ¼ 0.619 P ¼ 0.537 P ¼ 0.363 P ¼ 0.870 P ¼ 0.182
F ¼ 2.504 F ¼ 2.866 F ¼ 0.003 F ¼ 1.518 F ¼ 0.034 F ¼ 6.112
P ¼ 0.119 P ¼ 0.095 P ¼ 0.953 P ¼ 0.223 P ¼ 0.852 P ¼ 0.019
F ¼ 2.267 F ¼ 0.083 F ¼ 0.179 F ¼ 5.241 F ¼ 0.233 F ¼ 0.015
P ¼ 0.137 P ¼ 0.774 P ¼ 0.673 P ¼ 0.025 P ¼ 0.630 P ¼ 0.901
F ¼ 1.127 F ¼ 4.149 F ¼ 0.722 F ¼ 1.487 F ¼ 0.919 F ¼ 9.173
P ¼ 0.292 P ¼ 0.046 P ¼ 0.398 P ¼ 0.227 P ¼ 0.341 P ¼ 0.005
F ¼ 5.633 F ¼ 1.116 F ¼ 0.497 F ¼ 5.185 F ¼ 0.225 F ¼ 19.570
P ¼ 0.021 P ¼ 0.295 P ¼ 0.483 P ¼ 0.026 P ¼ 0.636 P < 0.001
F ¼ 0.127 F ¼ 1.026 F ¼ 0.344 F ¼ 0.110 F ¼ 0.145 F ¼ 0.756
P ¼ 0.722 P ¼ 0.315 P ¼ 0.559 P ¼ 0.740 P ¼ 0.704 P ¼ 0.391
F ¼ 0.002 F ¼ 12.731 F ¼ 0.141 F ¼ 8.047 F ¼ 0.151 F ¼ 0.596
P ¼ 0.958 P ¼ 0.007 P ¼ 0.716 P ¼ 0.021 P ¼ 0.707 P ¼ 0.462
F ¼ 6.802 F ¼ 3.337 F ¼ 2.907 F ¼ 7.316 F ¼ 1.648 F ¼ 25.507
P ¼ 0.031 P ¼ 0.105 P ¼ 0.126 P ¼ 0.026 P ¼ 0.235 P < 0.001
F ¼ 0.023 F ¼ 0.000 F ¼ 0.133 F ¼ 2.302 F ¼ 0.077 F ¼ 0.001
P ¼ 0.881 P ¼ 0.984 P ¼ 0.724 P ¼ 0.167 P ¼ 0.787 P ¼ 0.972
ortical total volume; CDI ¼ connectivity density index, SMI ¼ structure model index,
. Bold values indicate statistical signiﬁcance at P < 0.
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Fig. 4. Degree of synovitis in CCR5¡/¡ andWTmice. The sham-operated side of both CCR5/ (A) and WT (B) mice after DMM showed normal plasticity and cellularity at 8-weeks
after DMM. The DMM sides in CCR5/ mice (C) and WT mice (D) showed more hyperplasia and increased cell density compared to sham-operated knees following induction of
DMM at 8-weeks. The synovitis score at 4-weeks (N ¼ 16 for WT, N ¼ 14 for CCR5/) (E), 8-weeks (N ¼ 14 for WT, N ¼ 16 for CCR5/) (F) and at 12-weeks (N ¼ 6 each genotype)
(G) from all the four quadrants of three sections from each knee was based on the synovial lining thickness and the synovial stromal cell density. We observed no statistically
signiﬁcant differences in degree of synovitis between the two genotypes. Arrows show synovial hyperplasia and increased cell density. F ¼ femur; L ¼ ligament. Magniﬁcation 200
(Scale bar ¼ 100 mm). Graphs represent mean ± 95% CI.
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cells38. In addition, activated synovium may produce proteases,
catabolic mediators, and cytokines that accelerate the progression
of OA35,38. It has been reported that CCR5 is expressed in OA sy-
novial ﬁbroblasts, therefore, we expected to see less synovitis in
CCR5/ mice than WT. While we were unable to observe a sta-
tistically signiﬁcant difference among the genotypes/procedure
combinations for hyperplasia or synovial cell density, we did see a
slightly higher overall synovitis in DMM knees of WT compared to
CCR5/ at 4- and 8-weeks [Fig. 2(E and F)] that resolved at 12-
weeks. Other studies17,39 in rats have shown blockade of CCR5 in
an adjuvant-induced arthritis model resulted in reduced inﬂam-
mation of synovium17. In addition, CCR5 antagonists have been
reported to reduce joint destruction and synovitis in collagen-
induced arthritis, both in monkeys39 and mice40. A possible
explanation for the differences in the effect on synovitis between
our ﬁndings and those reported above may reside in the nature of
the arthritis models: collagenase-induced arthritis (as well as
adjuvant-induced arthritis) is more inﬂammatory41,42 than theslowly eroding OA induced by DMM surgery28. Our ﬁndings suggest
that cartilage degeneration can proceed without signiﬁcant syno-
vitis. Despite the evidence for the pro-inﬂammatory role of CCR5,
several studies suggest its anti-inﬂammatory role27,43. Therefore,
we suggest that further mechanistic studies are needed to inves-
tigate the roles of CCR5 and its ligands in modulating changes in
cartilage following a traumatic joint injury.
Our ﬁndings indicate that there are small baseline differences in
few bone parameters between the two genotypes (but not in
response to surgery). However, the biological signiﬁcance of these
differences is difﬁcult to predict with these data. In this study,
measurements from the lateral and medial compartments of the
tibial plateau were combined. In others when lateral and medial
compartments were analyzed separately, medial subchondral bone
thickening was correlated with the degree of cartilage damage29,32.
The lack of signiﬁcant genotype-by-procedure interaction effect
suggests that the response of the bone to DMM in CCR5-deﬁcient
mice is not different from that of WT mice. This ﬁnding is in line
with a previous study that has shown that expression of RANTES,
K. Takebe et al. / Osteoarthritis and Cartilage 23 (2015) 454e461460an inducer of CCR519, is not upregulated as much in traumatic
injury as is in OA and rheumatoid arthritis44.
A limitation associated with the current study is the use of
contralateral limb as sham-operated because this approach could
pose issues such as gait modiﬁcation and movement provoked
pain. In spite of studies that report use of sham and operated knees
in different mice32,45, there are also reports using sham and
surgery-operated knees within the same animal29,46. Interestingly,
in unpublished observations, we noted that the measurements of
bone parameters of sham-operated knees differed depending on
whether the contralateral knee was itself a sham or DMM-operated
knee. Although debatable, combining sham and DMMoperations in
the same mouse provides a better control for the effect of the
surgery up to but not including transection of the MMTL.
Taken together, our ﬁndings demonstrate a protective role of the
CCR5-ablation in post-traumatic OA development through modu-
lating changes in cartilage (less degeneration), without involving
changes in bone and synovium. Therefore, CCR5 may be a target for
intervention after traumatic insult to the articular joint.
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